ACADIA Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (67)

Latest Posts

About This Stock More About This Stock
Acadia Upgraded To Buy From Neutral At Goldman Sachs
Article By: The Fly
Tuesday, March 31, 2020 5:54 AM EDT
Goldman Sachs analyst Salveen Richter upgraded Acadia Pharmaceuticals to Buy from Neutral with a price target of $72, up from $45.
In this article: ACAD
The Bull Is Back, And All-Time Highs May Not Be Far Behind
Article By: Michael J. Kramer
Wednesday, March 4, 2020 10:14 PM EDT
Stocks rose by over 4.2% to finish the day at 3,130.
In this article: SWKS, SPY, VIX, V, AAPL, ACAD, SPLK
7 Monster Stock Market Predictions For The Week Of February 23
Article By: Michael J. Kramer
Sunday, February 23, 2020 12:37 PM EDT
It will not be a busy week in-terms of economic news low, but we will likely see a great amount of volatility. Markets will still be trying to figure out what the potential impact of the coronavirus is on the economy.
False Alarm, Stocks Midday Plunge Prove To Be Just A Mild Overreaction
Article By: Michael J. Kramer
Thursday, February 20, 2020 9:27 PM EDT
Markets in turmoil, the next correction is coming, the end of days are upon us.
In this article: AMD, ACAD, SPY, SPX, AMZN, BABA
Stocks Rebound Sharply Filling Gaps, But Not Out Of Danger Zone
Article By: Michael J. Kramer
Tuesday, January 28, 2020 10:27 PM EDT
Stocks snapped their two-day losing streak with the S&P 500 rising by over 1.2% to close around 3,280.
In this article: AMD, SPY, AAPL, SQ, ACAD, NFLX


Latest Tweets for $ACAD

No tweets yet!


Sunday Trio Of Short Ideas
All Things Tech 8/28/2017 3:36:31 AM

100% agreement on $BWLD especially since it has been flat for months in a bullish market with more room to fall.

I disagree with $AMD. If AMD falls below the SMA200, absolutely short, but the Triple Bottom off 12.00 is a cause of concern + a previous ER beat + Q3 ER beat likely & sitting in oversold territory according to (MFI). $SOXX shows a Pennant as well.

$ACAD long-term is down, but short term is up. Above the SMA 20, 50 & 200.

Both AMD & ACAD is big risk little reward in my book unless the Days to Cover is a big enough window. Otherwise just not worth it in my book.

1 to 1 of 1 comments